BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 32665938)

  • 21. Shortened activated partial thromboplastin time: causes and management.
    Lippi G; Salvagno GL; Ippolito L; Franchini M; Favaloro EJ
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):459-63. PubMed ID: 20614573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermatoporosis: a chronic cutaneous insufficiency/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments.
    Kaya G; Saurat JH
    Dermatology; 2007; 215(4):284-94. PubMed ID: 17911985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
    Mantovani Cardoso E; Hundal J; Feterman D; Magaldi J
    Clin Rheumatol; 2020 Sep; 39(9):2811-2815. PubMed ID: 32720260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection.
    Lorenzo-Villalba N; Maouche Y; Syrovatkova A; Pham F; Chahbazian JB; Pertoldi P; Andrès E; Zulfiqar AA
    Eur J Case Rep Intern Med; 2020; 7(7):001769. PubMed ID: 32665938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid syndrome.
    Gezer S
    Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disseminated intravascular coagulation with congestive heart failure and left ventricular thrombus: a case report with literature review of 7 cases.
    Belov D; Lyubarova R; Fein S; Torosoff M
    Am J Case Rep; 2015 Jan; 16():53-6. PubMed ID: 25637329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy.
    Turshudzhyan A
    Cureus; 2020 May; 12(5):e8150. PubMed ID: 32550069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection.
    Zanza C; Racca F; Longhitano Y; Piccioni A; Franceschi F; Artico M; Abenavoli L; Maiese A; Passaro G; Volonnino G; La Russa R
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33572570
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.